Merck says Covid pill 'active' against Omicron

  • World
  • Saturday, 29 Jan 2022

WASHINGTON: Merck's anti-Covid pill remains "active" against the Omicron variant, the US drugmaker said Friday (Jan 28), citing results from six laboratory studies.

The oral treatment, called molnupiravir, is taken within five days of symptom onset and was shown in a pre-Omicron trial of 1,400 participants to reduce Covid hospitalisations and deaths by 30 percent among at-risk people.

Subscribe now to our Premium Plan for an ad-free and unlimited reading experience!

Merck , anti-Covid pill , Omicron variant


Next In World

Zelenskiy guarded on Ukraine's counteroffensive, but says generals happy
Annecy knife attack suspect detained, prosecutor says
Rare Chinese Buddha statue up for auction at Bonhams in Paris
Sudanese capital quiet as 24-hour ceasefire takes hold
Spain's Socialist PM backs alliance between two leftist parties
Russian strikes kill three in Odesa, hit Poltava air base - Ukraine
Annecy knife attack suspect placed in detention - prosecutor
Pope recovering well from surgery but to skip Sunday blessing
Ukraine's army reports new gains against Russian forces near Bakhmut
German Chancellor Scholz says he plans to speak to Putin soon

Others Also Read